Synthetic Approaches to New Drugs Approved during 2018
Andrew C. Flick, Carolyn A. Leverett, Hong X. Ding, Emma L. McInturff, Sarah J. Fink, Christopher J. Helal, Jacob C. DeForest, Peter Morse, Subham Mahapatra, Christopher J. O’Donnell
Abstract
New drugs introduced to the market every year represent privileged structures for particular biological targets. These new chemical entities (NCEs) provide insight into molecular recognition while serving as leads for designing future new drugs. This annual review describes the most likely process-scale synthetic approaches to 39 new chemical entities approved for the first time globally in 2018.
Topics & Concepts
ChemistryPharmacologyMedicineChemical Reactions and IsotopesBiochemical and Molecular ResearchChemistry and Chemical Engineering